TGA Orders Withdrawal Of Four Aspen Australia-Marketed Painkillers
This article was originally published in PharmAsia News
Executive Summary
Four pain killers marketed by Aspen Australia have been ordered off the Australian market by the Therapeutic Goods Administration because of a concern of serious side effects.